Identifying Protein-metabolite Networks Associated with COPD Phenotypes

Area of Science:

• Pulmonary Medicine
• Systems Biology
• Biomarker Discovery

Background:

• Chronic obstructive pulmonary disease (COPD) is characterized by airflow obstruction, predominantly affecting smokers.
• Current understanding of additional risk factors and molecular signatures in COPD remains incomplete.
• Identifying novel biomarkers is crucial for understanding COPD pathogenesis and progression.

Purpose of the Study:

• To integrate proteomic and metabolomic data using Sparse Multiple Canonical Correlation Network (SmCCNet) to identify novel protein-metabolite networks associated with COPD.
• To discover interpretable molecular networks that may reveal biomarkers overlooked by traditional methods.
• To enhance the understanding of COPD molecular signatures and their association with lung function and emphysema.

Main Methods:

• Utilized Sparse Multiple Canonical Correlation Network (SmCCNet) analysis to integrate proteomic and metabolomic data.
• Analyzed blood samples from 1008 participants in the COPDGene study.
• Identified protein-metabolite networks correlated with lung function and emphysema severity.

Main Results:

• A significant protein-metabolite network (13 proteins, 7 metabolites) showed a strong negative correlation with lung function (r = -0.34, p < 2.5 × 10⁻²⁸).
• Another network (13 proteins, 10 metabolites) was significantly correlated with percent emphysema (r = -0.27, p < 2.6 × 10⁻¹⁷).
• These networks provide a multi-dimensional view of COPD molecular pathology.

Conclusions:

• Protein-metabolite networks identified through SmCCNet offer valuable insights into COPD.
• These integrated -omic approaches can uncover novel biomarkers for lung function and emphysema.
• Network-based analyses complement single-biomarker strategies for a comprehensive understanding of COPD.